Clinical Trials in Miami

Showing 1281-1300 of 9,821 trials

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

NCT05136703

The purpose of this randomized controlled trial is to understand how a cognitive-behavioral treatment (a form of psychological treatment) for depression changes the gut microbiome (micro-organisms that regulate the health of the gut), immune system, and the brain functioning in people living with HIV.

DepressionHIV-1-infectionInflammation

Florida International University150 participantsStarted Aug 2022

Coral Gables, Florida, United States • Miami, Florida, United States

COMPLETEDPhase 2< 1 mile

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

NCT06717425

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07976016) for the potential treatment of obesity. The study will compare the experiences of participants taking the study medicine (PF-07976016) to those of participants who take placebo (a lookalike substance that contains no active study medicine). The aim is to measure the body's response to the study medicine, including any changes in participants' body weight and how well they tolerate the study medicine.

Obesity

Pfizer263 participantsStarted Dec 2024

Anaheim, California, United States • San Diego, California, United States • Aurora, Colorado, United States +35 more locations

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

Find Trials by Condition in Miami

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

PrEP Affect Regulation Treatment Innovation

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)

Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.

A Study of AL102 in Patients With Progressing Desmoid Tumors

Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors

A Study of EBC-129 in Advanced Solid Tumours

Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2